{"DataElement":{"publicId":"2180644","version":"1","preferredName":"T-Lymphocyte Transplant CD3+ Cell Infusion Dose","preferredDefinition":"the number of T lymphocyte cells with CD3 present, value in cells/kg x 10^8, that are administered to a patient as part of a transplant procedure.","longName":"T_TSPL_CD3_INF_DOSE","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195846","version":"1","preferredName":"T-Lymphocyte Transplant CD3+ cell Infusion","preferredDefinition":"information related to the infusion of CD3+ T lymphocytes as part of the transplant procedure.","longName":"TLYMPH_TSPL_CD3_INF","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660550","version":"1","preferredName":"T-Lymphocyte Transplant","preferredDefinition":"One type of white blood cell that attacks virus-infected cells, foreign cells, and cancer cells.  T cells also produce a number of substances that regulate the immune response.:Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.","longName":"C12476:C12981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Lymphocyte","conceptCode":"C12476","definition":"A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-F3E3-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660919","version":"1","preferredName":"CD3+ cell Infusion","preferredDefinition":"No Value Exists:A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.","longName":"C0882828:C15388","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD3+ cell","conceptCode":"C0882828","definition":"No Value Exists","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-DE21-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF51034-DE20-3241-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180643","version":"1","preferredName":"T-Lymphocyte Transplant CD3+ Cell Infusion Dose","preferredDefinition":"information related to the infusion dose of T cells for a transplant patient.","longName":"T_TSPL_CD3_INF_DOSE","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184291","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"Dose","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1B95-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D20F5991-72E1-3910-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"CAMPBELB","dateModified":"2005-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Number of T cells (CD3) infused","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D20DE34D-EE94-39EA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"CAMPBELB","dateModified":"2005-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}